Impact of COVID-19 on Delay in Cancer Diagnostic Testing
TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity
A comprehensive genomic profiling approach to detect functional translocations and genomic alterations in a single tube workflow
A novel comprehensive breakpoint-targeted assay for clinically actionable RNA fusions and aberrant RNAs in solid tumors.
An efficient probe design algorithm for direct fusion targeting from RNA
Characterizing viral mRNA and immuno-protein expression in head and neck squamous cell carcinoma using a novel automated RNAScope™/Polaris™ integrated assay
Co-detection of a tumor-infiltrating lymphocyte immunofluorescence (IF) panel and cytokine RNA in-situ hybridization (ISH) markers in non-small cell lung cancer (NSCLC) tumor microenvironment using combined MultiOmyx and RNAScope platforms
Comprehensive Analysis of immuno oncology markers in the TME of solid tumor samples using GeoMx™ Digital Spatial Profiler (DSP) and MultiOmyx™ Hyperplexed Immunofluorescence (IF).